Oncolytics (ONCY) Biotech announced the appointment of Andrew Aromando as Chief Business Officer. Aromando most recently served as COO at Ambrx Biopharma.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks